GAMMA Investing LLC lifted its position in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 816.3% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 37,650 shares of the company's stock after purchasing an additional 33,541 shares during the quarter. GAMMA Investing LLC's holdings in Sotera Health were worth $439,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in SHC. Quarry LP purchased a new position in shares of Sotera Health in the fourth quarter worth $28,000. Blue Trust Inc. raised its stake in shares of Sotera Health by 504.0% in the fourth quarter. Blue Trust Inc. now owns 4,192 shares of the company's stock worth $57,000 after purchasing an additional 3,498 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock worth $82,000 after purchasing an additional 1,640 shares during the last quarter. Sterling Capital Management LLC raised its stake in shares of Sotera Health by 58.5% in the fourth quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock worth $124,000 after purchasing an additional 3,331 shares during the last quarter. Finally, PNC Financial Services Group Inc. raised its stake in shares of Sotera Health by 39.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock worth $127,000 after purchasing an additional 2,627 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors.
Sotera Health Trading Down 2.6%
Shares of NASDAQ SHC traded down $0.30 during midday trading on Monday, hitting $11.09. The company's stock had a trading volume of 1,741,518 shares, compared to its average volume of 1,236,166. The company has a current ratio of 2.46, a quick ratio of 2.19 and a debt-to-equity ratio of 5.55. The business's 50 day moving average is $11.93 and its two-hundred day moving average is $12.44. Sotera Health Company has a 12-month low of $9.53 and a 12-month high of $17.08. The firm has a market cap of $3.15 billion, a P/E ratio of 138.64 and a beta of 1.87.
Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.12 by $0.02. The company had revenue of $254.52 million for the quarter, compared to the consensus estimate of $245.56 million. Sotera Health had a return on equity of 41.08% and a net margin of 2.24%. Sotera Health's quarterly revenue was up 2.6% on a year-over-year basis. During the same period last year, the business posted $0.13 EPS. As a group, equities research analysts expect that Sotera Health Company will post 0.61 EPS for the current year.
Analysts Set New Price Targets
A number of analysts recently commented on the company. The Goldman Sachs Group upgraded Sotera Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $14.00 to $17.00 in a research report on Monday, May 5th. Piper Sandler reduced their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. Wall Street Zen cut Sotera Health from a "buy" rating to a "hold" rating in a research report on Saturday, June 7th. Finally, Barclays reduced their price objective on Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $15.80.
View Our Latest Research Report on SHC
About Sotera Health
(
Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Further Reading
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
